激素疗法和卵巢癌的治疗方法
Lina Steinrud Mørch1, Ellen Løkkegaard, Anne Helms Andreasen
1Gynaecological Clinic, Rigshospitalet, Copenhagen University, 2100 Copenhagen, Denmark. linamorch@yahoo.dk
JAMA
|July 16, 2009
概括
绝经后的激素治疗增加了卵巢癌的风险,无论配方或持续时间如何. 风险在停止后降低,绝对增加约为每8300名女性每年增加1例.
科学领域:
- 妇科 妇科医生 妇科
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 绝经后使用激素治疗 (HT) 与卵巢癌风险增加有关.
- 关于不同的HT配方,疗法和服用途径如何影响这种风险的数据有限.
研究的目的:
- 评估各种激素疗法与绝经前和绝经后妇女的卵巢癌风险之间的关联.
主要方法:
- 丹麦 (1995-2005) 全国范围的前性队列研究包括近100万名年龄在50-79岁的女性.
- 用个人级别的处方数据和国家癌症登记册来跟踪HT使用和卵巢癌发病率.
- 普森回归分析评估了荷尔蒙暴露作为依赖时间的共变量.
主要成果:
- 与非使用者相比,目前的HT使用者显示所有卵巢癌的风险增加了38% (IRR1.38),卵巢上皮癌的风险增加了44% (IRR1.44).
- 自上次使用HT以来,卵巢癌风险随着时间的推移而降低,在2-4年后变得无意义.
- 根据HT配方,持续时间或孕激素类型,没有观察到显著的风险差异.
结论:
- 激素治疗与卵巢癌的风险增加有关.
- 这种增加的风险在不同的HT配方,剂量,疗法和服用途径中是一致的.
- 这些发现强调了考虑使用激素治疗的女性卵巢癌风险的重要性.
相关概念视频
Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...

